At onset | Group I, n = 216 | Group II, n = 92 | Group III, n = 223 | Group IV, n = 158 | P value for trend |
Hospital mortality, n (%) | 71 (32.9) | 33 (35.9) | 85 (38.1) | 53 (33.5) | 0.65 |
ICU mortality, n (%) | 50 (23.1) | 25 (27.2) | 59 (26.5) | 35 (22.2) | 0.99 |
90-day mortality, n (%) | 86 (39.8) | 36 (39.1) | 103 (46.2) | 66 (41.8) | 0.40 |
VFD28, days [IQR] | 22 [5–25] | 22 [0–24] | 21 [0–25] | 21 [3–25] | 0.28# |
ICUFD28, days [IQR] | 23 [19–25] | 22 [18–24] | 22 [18–25] | 22 [17–24] | 0.09# |
At 24 h | Group I, n = 296 | Group II, n = 96 | Group III, n = 177 | Group IV, n = 120 | P value for trend |
Hospital mortality, n (%) | 90 (30.4) | 29 (30.2) | 66 (37.3) | 57 (47.5) | < 0.01 |
ICU mortality, n (%) | 54 (18.2) | 19 (19.8) | 51 (28.8) | 45 (37.5) | < 0.01 |
90-day mortality, n (%) | 119 (40.2) | 33 (34.4) | 75 (42.4) | 64 (53.3) | 0.03 |
VFD28, days [IQR] | 23 [14–25] | 21 [4–24] | 22 [0–25] | 16 [0–23] | < 0.01# |
ICUFD28, days [IQR] | 22 [19–25] | 21 [15–25] | 22 [19–25] | 22 [15–25] | 0.02# |